{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:13:12Z","timestamp":1778908392077,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["810957 \/An"],"award-info":[{"award-number":["810957 \/An"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Hypertension"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ijchy.2021.100088","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T13:56:02Z","timestamp":1623765362000},"page":"100088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system"],"prefix":"10.1016","volume":"9","author":[{"given":"Jaejin","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5825-9248","authenticated-orcid":false,"given":"Tiffany Q.","family":"Luong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael K.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Mefford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7827-7654","authenticated-orcid":false,"given":"Teresa N.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Creekmur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Sum","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W.","family":"Brettler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeline L.","family":"Ong-Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijchy.2021.100088_bib1","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin ii receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijchy.2021.100088_bib2","article-title":"Renin-angiotensin system blockers, risk of sars-cov-2 infection and outcomes from covid-19: systematic review and meta-analysis","author":"Lee","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ijchy.2021.100088_bib3","first-page":"100627","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of covid-19 infection or severe disease: systematic review and meta-analysis","volume":"31","author":"Caldeira","year":"2020","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"10.1016\/j.ijchy.2021.100088_bib4","article-title":"Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor\/angiotensin ii receptor blocker use during coronavirus disease 2019: beyond confounding","author":"Cohen","year":"2020","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.ijchy.2021.100088_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with testing positive for coronavirus disease 2019 (covid-19)","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijchy.2021.100088_bib6","article-title":"Effects of renin-angiotensin-aldosterone system inhibitors on disease severity and mortality in patients with covid-19: a meta-analysis","author":"Zhang","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.ijchy.2021.100088_bib7","first-page":"544","article-title":"Systemic implementation strategies to improve hypertension: the kaiser permanente southern California experience","volume":"30","author":"Sim","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijchy.2021.100088_bib8","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit. Care"},{"key":"10.1016\/j.ijchy.2021.100088_bib9","article-title":"Weight trimming and propensity score weighting","volume":"6","author":"Lee","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ijchy.2021.100088_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/0962280219870836","article-title":"Subgroup balancing propensity score","volume":"29","author":"Dong","year":"2020","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.ijchy.2021.100088_bib11","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use and covid-19 infection among 824 650 patients with hypertension from a us integrated healthcare system","author":"An","year":"2020","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.ijchy.2021.100088_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (covid-19) infection in wuhan, China","author":"Li","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijchy.2021.100088_bib13","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","article-title":"Association of hypertension and antihypertensive treatment with covid-19 mortality: a retrospective observational study","volume":"41","author":"Gao","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijchy.2021.100088_bib14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/HJH.0000000000002658","article-title":"Association between renin-angiotensin-aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment","volume":"39","author":"Lahens","year":"2021","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.ijchy.2021.100088_bib15","article-title":"Covid-19 and survival in maintenance dialysis","author":"Sim","year":"2020","journal-title":"Kidney Med"},{"key":"10.1016\/j.ijchy.2021.100088_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ahj.2020.05.002","article-title":"Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (sars-cov-2)--the brace corona trial","volume":"226","author":"Lopes","year":"2020","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijchy.2021.100088_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30558-0","article-title":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with covid-19: a prospective, randomised, open-label trial","author":"Cohen","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijchy.2021.100088_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36462","article-title":"Association of social and demographic factors with covid-19 incidence and death rates in the us","volume":"4","author":"Karmakar","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijchy.2021.100088_bib19","series-title":"The Association between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45,418 Symptomatic Patients with Hypertension: an Observational Cohort Study","first-page":"2020","author":"Sheppard","year":"1979"},{"key":"10.1016\/j.ijchy.2021.100088_bib20","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41440-020-00541-w","article-title":"Blood pressure control and adverse outcomes of covid-19 infection in patients with concomitant hypertension in wuhan, China","volume":"43","author":"Ran","year":"2020","journal-title":"Hypertens. Res. : Off. J. Jpn. Soc. Hypertens."}],"container-title":["International Journal of Cardiology Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590086221000136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590086221000136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:52:41Z","timestamp":1778907161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590086221000136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":20,"alternative-id":["S2590086221000136"],"URL":"https:\/\/doi.org\/10.1016\/j.ijchy.2021.100088","relation":{},"ISSN":["2590-0862"],"issn-type":[{"value":"2590-0862","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijchy.2021.100088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100088"}}